Extrapyramidal adverse events and anticholinergics use after the long-term treatment of patients with schizophrenia with the new long-acting antipsychotic Risperidone ISM®: results from matching-adjusted indirect comparisons versus once-monthly formulations of Paliperidone palmitate and Aripiprazole monohydrate in 52-week studies

  1. Sánchez, P.
  2. Álamo, C.
  3. Almendros, M.
  4. Schlueter, M.
  5. Tasoulas, A.
  6. Martínez, J.
Annals of General Psychiatry

ISSN: 1744-859X

Year of publication: 2023

Volume: 22

Issue: 1

Type: Article

DOI: 10.1186/S12991-023-00464-Z GOOGLE SCHOLAR lock_openOpen access editor